C12N 2760/20263
By chemical treatment
Official title: by chemical treatment
C12N2760/20263 (By chemical treatment) appears on 30 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 30
- Published applications
- 7
- Assignees
- 10
- Inventors
- 44
- Latest grant
- 7 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 1 |
| 2003 | 3 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Non-replicating virus-derived particles and uses thereof7 Sep 2021US 11,110,138 B2Celverum Inc.
- Caprylate viral deactivation5 May 2015US 9,023,797 B2Grifols, S.A.
- Methods and compositions for the selective modification of nucleic acids9 Sep 2003US 6,617,157 B1V. I. Technologies, Inc.
- Process for the sterilization of biological compositions and the product thereby15 Apr 2003US 6,548,242 B2New York Blood Center, Inc.
- Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light1 Apr 2003US 6,541,229 B1New York Blood Center, Inc.
- Non-replicating virus-derived particles and uses thereof11 Nov 2021US 2021/0346441 A1Celverum Inc.
- Non-replicating virus-derived particles and uses thereof12 Nov 2015US 2015/0320810 A1Celverum Inc.
- Caprylate viral deactivation12 Jun 2014US 2014/0163101 A1Grifols, S.A.
- Methods and compositions for the selective modification of nucleic acids18 Mar 2004US 2004/0053316 A1V. I. Technologies, Inc.
- Methods and compositions for the selective modification of nucleic30 Oct 2003US 2003/0202986 A1
Most cited
By later US patents
- Photodynamic inactivation of viruses in blood cell-containing compositions94US 5,120,649 ANew York Blood Center, Inc. · 1992
- Preparation of inactivated viral vaccines92US 4,693,981 AAdvanced Genetics Research Institute · 1987
- Photodynamic inactivation of viruses in cell-containing compositions80US 5,232,844 ANew York Blood Center, Inc. · 1993
- Processes for photoreactive inactivation of a virus in blood cell or coagulation factor containing compositions and use thereof for preparing compositions useful for transfusion71US 6,294,361 B1New York Blood Center, Inc. · 2001
- Inactivation of viruses in labile blood derivatives64US 4,613,501 ANew York Blood Center, Inc. · 1986